These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 20036050)
21. Recombinant adenovirus-p53 gene transfer and cell-specific growth suppression of human cervical cancer cells in vitro and in vivo. Ahn WS; Bae SM; Lee KH; Lee JM; Namkoong SE; Chun HJ; Kim CK; Kim YW Gynecol Oncol; 2004 Feb; 92(2):611-21. PubMed ID: 14766255 [TBL] [Abstract][Full Text] [Related]
22. Human papillomavirus type 16 E6 inactivation of p53 in normal human mammary epithelial cells promotes tamoxifen-mediated apoptosis. Seewaldt VL; Mrózek K; Dietze EC; Parker M; Caldwell LE Cancer Res; 2001 Jan; 61(2):616-24. PubMed ID: 11212259 [TBL] [Abstract][Full Text] [Related]
23. Inhibition of cervical cancer cell growth in vitro and in vivo with lentiviral-vector delivered short hairpin RNA targeting human papillomavirus E6 and E7 oncogenes. Gu W; Putral L; Hengst K; Minto K; Saunders NA; Leggatt G; McMillan NA Cancer Gene Ther; 2006 Nov; 13(11):1023-32. PubMed ID: 16810314 [TBL] [Abstract][Full Text] [Related]
24. Oncolytic adenovirus expressing a p53 variant resistant to degradation by HPV E6 protein exhibits potent and selective replication in cervical cancer. Heideman DA; Steenbergen RD; van der Torre J; Scheffner M; Alemany R; Gerritsen WR; Meijer CJ; Snijders PJ; van Beusechem VW Mol Ther; 2005 Dec; 12(6):1083-90. PubMed ID: 16085463 [TBL] [Abstract][Full Text] [Related]
25. Intratumor injection of small interfering RNA-targeting human papillomavirus 18 E6 and E7 successfully inhibits the growth of cervical cancer. Fujii T; Saito M; Iwasaki E; Ochiya T; Takei Y; Hayashi S; Ono A; Hirao N; Nakamura M; Kubushiro K; Tsukazaki K; Aoki D Int J Oncol; 2006 Sep; 29(3):541-8. PubMed ID: 16865269 [TBL] [Abstract][Full Text] [Related]
26. E6 and e7 gene silencing and transformed phenotype of human papillomavirus 16-positive oropharyngeal cancer cells. Rampias T; Sasaki C; Weinberger P; Psyrri A J Natl Cancer Inst; 2009 Mar; 101(6):412-23. PubMed ID: 19276448 [TBL] [Abstract][Full Text] [Related]
27. Activation of p53 in cervical cancer cells by human papillomavirus E6 RNA interference is transient, but can be sustained by inhibiting endogenous nuclear export-dependent p53 antagonists. Koivusalo R; Mialon A; Pitkänen H; Westermarck J; Hietanen S Cancer Res; 2006 Dec; 66(24):11817-24. PubMed ID: 17178878 [TBL] [Abstract][Full Text] [Related]
28. RNA interference against human papillomavirus oncogenes in cervical cancer cells results in increased sensitivity to cisplatin. Putral LN; Bywater MJ; Gu W; Saunders NA; Gabrielli BG; Leggatt GR; McMillan NA Mol Pharmacol; 2005 Nov; 68(5):1311-9. PubMed ID: 16120770 [TBL] [Abstract][Full Text] [Related]
29. The role of HPV oncoproteins and cellular factors in maintenance of hTERT expression in cervical carcinoma cells. Jeong Seo E; Jung Kim H; Jae Lee C; Tae Kang H; Seong Hwang E Gynecol Oncol; 2004 Jul; 94(1):40-7. PubMed ID: 15262117 [TBL] [Abstract][Full Text] [Related]
30. HPV-18 E6 inhibits p53 DNA binding activity regardless of the oligomeric state of p53 or the exact p53 recognition sequence. Thomas M; Massimi P; Banks L Oncogene; 1996 Aug; 13(3):471-80. PubMed ID: 8760288 [TBL] [Abstract][Full Text] [Related]
31. The role of E6AP in the regulation of p53 protein levels in human papillomavirus (HPV)-positive and HPV-negative cells. Talis AL; Huibregtse JM; Howley PM J Biol Chem; 1998 Mar; 273(11):6439-45. PubMed ID: 9497376 [TBL] [Abstract][Full Text] [Related]
32. Pitx2a binds to human papillomavirus type 18 E6 protein and inhibits E6-mediated P53 degradation in HeLa cells. Wei Q J Biol Chem; 2005 Nov; 280(45):37790-7. PubMed ID: 16129685 [TBL] [Abstract][Full Text] [Related]
33. Knockdown of CITED2 using short-hairpin RNA sensitizes cancer cells to cisplatin through stabilization of p53 and enhancement of p53-dependent apoptosis. Wu ZZ; Sun NK; Chao CC J Cell Physiol; 2011 Sep; 226(9):2415-28. PubMed ID: 21660965 [TBL] [Abstract][Full Text] [Related]
34. The stability of the human papillomavirus E6 oncoprotein is E6AP dependent. Tomaić V; Pim D; Banks L Virology; 2009 Oct; 393(1):7-10. PubMed ID: 19700180 [TBL] [Abstract][Full Text] [Related]
35. Identification of MicroRNAs That Stabilize p53 in Human Papillomavirus-Positive Cancer Cells. Martínez-Noël G; Szajner P; Kramer RE; Boyland KA; Sheikh A; Smith JA; Howley PM J Virol; 2022 Feb; 96(4):e0186521. PubMed ID: 34878887 [TBL] [Abstract][Full Text] [Related]
36. GRIM-19 disrupts E6/E6AP complex to rescue p53 and induce apoptosis in cervical cancers. Zhou Y; Wei Y; Zhu J; Wang Q; Bao L; Ma Y; Chen Y; Feng D; Zhang A; Sun J; Nallar SC; Shen K; Kalvakolanu DV; Xiao W; Ling B PLoS One; 2011; 6(7):e22065. PubMed ID: 21765936 [TBL] [Abstract][Full Text] [Related]
37. The global transcriptional effects of the human papillomavirus E6 protein in cervical carcinoma cell lines are mediated by the E6AP ubiquitin ligase. Kelley ML; Keiger KE; Lee CJ; Huibregtse JM J Virol; 2005 Mar; 79(6):3737-47. PubMed ID: 15731267 [TBL] [Abstract][Full Text] [Related]
38. Upregulation of p18Ink4c expression by oncogenic HPV E6 via p53-miR-34a pathway. Wang X; Meyers C; Guo M; Zheng ZM Int J Cancer; 2011 Sep; 129(6):1362-72. PubMed ID: 21128241 [TBL] [Abstract][Full Text] [Related]
39. E3 ubiquitin ligase E6AP-mediated TSC2 turnover in the presence and absence of HPV16 E6. Zheng L; Ding H; Lu Z; Li Y; Pan Y; Ning T; Ke Y Genes Cells; 2008 Mar; 13(3):285-94. PubMed ID: 18298802 [TBL] [Abstract][Full Text] [Related]
40. BAG3 down-modulation sensitizes HPV18(+) HeLa cells to PEITC-induced apoptosis and restores p53. Cotugno R; Basile A; Romano E; Gallotta D; Belisario MA Cancer Lett; 2014 Nov; 354(2):263-71. PubMed ID: 25175321 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]